Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma
Annals of Pathology and Laboratory Medicine · 06.10.2024 · 11 (10) · A284-294
DOI: 10.21276/apalm.3398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Pathology and Laboratory Medicine, online erschienen am 06.10.2024. Verfasst von Aakanksha Rawat und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Infiltrating urothelial carcinoma is the most common histological variant (23.1%). This study was conducted to evaluate the immunohistochemical expression of PD-L1 in invasive urothelial carcinoma and to correlate PD-L1 expression with demographic data and the histological grade of urothelial carcinoma.
Methods
The study comprised a total of 65 cases of muscle-invasive urothelial carcinoma collected over a period of one year and evaluated for PD-L1 expression using the immunohistochemistry technique.
Results
Infiltrating urothelial carcinoma was the most common histological variant (23.1%), followed by poorly differentiated carcinoma (16.9%). PD-L1 positivity was observed in 47.7% of the total cases, while the remaining 52.3% showed no expression of PD-L1. Among the various histologic variants, poorly differentiated carcinoma (57.1%) was the largest group with weak expression of PD-L1; infiltrating urothelial carcinoma (26.7%) was the largest group with moderate expression of PD-L1, while the lymphoepithelioma-like variant (66.7%) was the largest group with strong expression of PD-L1. Our study was in concordance with other studies, showing that PD-L1 expression is not associated with clinicopathologic features like age, gender, and smoking status.
Conclusion
The present study shows a significant difference between the various groups in terms of the distribution of histologic variants and PD-L1 positivity according to the WHO classification (2016) as well as severity scoring by the IHC technique.
Zitieren
APA
Rawat, A., Gupta, M., Pawar, D. S., Singh, S., & Kumari, S. (2024). Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma. Annals of Pathology and Laboratory Medicine, 11(10), A284-294. https://doi.org/10.21276/apalm.3398
Vancouver
Rawat A, Gupta M, Pawar DS, Singh S, Kumari S. Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma. Annals of Pathology and Laboratory Medicine. 2024;11(10):A284-294. doi:10.21276/apalm.3398
BibTeX
@article{Rawat2024,
author = {Rawat, Aakanksha and Gupta, Monika and Pawar, Devendra Singh and Singh, Sunita and Kumari, Sujata},
title = {Assessment of Immunohistochemical Expression of Programmed Cell Death Ligand-1 in Invasive Urothelial Carcinoma},
journal = {Annals of Pathology and Laboratory Medicine},
year = {2024},
volume = {11},
number = {10},
pages = {A284--294},
doi = {10.21276/apalm.3398}
}
EUVIMED